Sage Therapeutics (SAGE) PT Lowered to $52 at Piper Sandler
Tweet Send to a Friend
Piper Sandler analyst Yasmeen Rahimi lowered the price target on Sage Therapeutics (NASDAQ: SAGE) to $52.00 (from $70.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
